Symbol="CRSP"
AssetType="Common Stock"
Name="Crispr Therapeutics AG"
Description="CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland."
CIK="1674416"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="BAARERSTRASSE 14, ZUG, CH"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4492197000"
EBITDA="-538492032"
PERatio="None"
PEGRatio="0"
BookValue="23.52"
DividendPerShare="0"
DividendYield="0"
EPS="-6.47"
RevenuePerShareTTM="1.283"
ProfitMargin="0"
OperatingMarginTTM="-5.6"
ReturnOnAssetsTTM="-0.145"
ReturnOnEquityTTM="-0.256"
RevenueTTM="100258000"
GrossProfitTTM="-570697000"
DilutedEPSTTM="-6.47"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="105.38"
AnalystTargetPrice="84.38"
TrailingPE="-"
ForwardPE="23.36"
PriceToSalesRatioTTM="253.26"
PriceToBookRatio="2.011"
EVToRevenue="178.1"
EVToEBITDA="-3.434"
Beta="1.618"
num_52WeekHigh="86.95"
num_52WeekLow="38.94"
num_50DayMovingAverage="60.16"
num_200DayMovingAverage="53.21"
SharesOutstanding="78935000"
DividendDate="None"
ExDividendDate="None"
symbol="CRSP"
open="59.29"
high="59.57"
low="56.50"
price="56.91"
volume="1006934.00"
latest_trading_day="2023-07-14"
previous_close="59.00"
change="-2.09"
change_percent="-3.5424%"
aroon_positive_momentum_days="77"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="77"
Volume_recent_avg="1257319"
Change_recent_avg="-0.11"
Delta_recent_avg="2.83"
Variance_recent_avg="1.42"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="77"
Aroon_momentum_negative="23"
image_negative_thumbnail_id_1="1160"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0194.jpeg"
image_negative_thumbnail_id_2="134"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0042.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="548"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_positive_thumbnail_id_1="1002"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0164.jpeg"
image_positive_thumbnail_id_2="623"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
